A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Clinical trial NCT02960022 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02960022
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2029-07-31
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.